Bio-Rad Laboratories, Inc. today announced the launch of a new simplified and robust workflow to more effectively evaluate antibodies used for measuring residual host cell protein (HCP) impurities in biotherapeutics. The two-dimensional electrophoresis (2-DE)- and western blotting (WB)-based workflow will be unveiled during the Well Characterized Biotechnology Pharmaceutical (WCBP) Symposium in Washington, D.C. January 29–31. [...]